Israel Englander Evolus, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Evolus, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 80,000 shares of EOLS stock, worth $871,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,000

Previous 899,377 91.1%

Holding current value

$871,200

Previous $9.76 Million 86.72%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.66 - $17.48 $1.39 Million - $2.28 Million	130,293 Added 14.49%	1,029,670 $16.7 Million
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $386,608 - $509,064	-36,996 Reduced 3.95%	899,377 $9.76 Million
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $671,767 - $1 Million	-67,244 Reduced 6.7%	936,373 $13.1 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $7.89 Million - $10.9 Million	-1,038,621 Reduced 50.86%	1,003,617 $10.6 Million
Q2 2023 Aug 14, 2023	SELL	$7.23 - $10.52 $3.14 Million - $4.57 Million	-434,257 Reduced 17.54%	2,042,238 $14.8 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $7.96 Million - $11.3 Million	1,019,305 Added 69.95%	2,476,495 $21 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $4.59 Million - $6.3 Million	703,402 Added 93.32%	1,457,190 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $1.69 Million - $2.98 Million	217,375 Added 40.52%	753,788 $6.07 Million
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $1.6 Million - $2.18 Million	156,431 Added 41.17%	536,413 $6.22 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $1.98 Million - $4.48 Million	379,982 New	379,982 $4.26 Million
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $999,056 - $1.56 Million	-186,044 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $1.01 Million - $1.87 Million	137,136 Added 280.4%	186,044 $1.42 Million
Q2 2021 Aug 16, 2021	SELL	$8.42 - $13.96 $1.52 Million - $2.51 Million	-180,074 Reduced 78.64%	48,908 $619,000
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $614,243 - $3.17 Million	191,951 Added 518.35%	228,982 $2.97 Million
Q4 2020 Feb 16, 2021	BUY	$2.92 - $4.84 $108,130 - $179,230	37,031 New	37,031 $124,000
Q2 2020 Aug 14, 2020	SELL	$3.53 - $6.17 $640,405 - $1.12 Million	-181,418 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$3.53 - $12.21 $1.4 Million - $4.83 Million	-395,891 Reduced 68.58%	181,418 $753,000
Q4 2019 Feb 14, 2020	BUY	$11.58 - $17.37 $4.72 Million - $7.07 Million	407,237 Added 239.45%	577,309 $7.03 Million
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $212,419 - $303,434	15,271 Added 9.86%	170,072 $2.66 Million
Q2 2019 Aug 15, 2019	BUY	$13.19 - $28.36 $400,738 - $861,633	30,382 Added 24.42%	154,801 $2.26 Million
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $1.64 Million - $3.53 Million	124,419 New	124,419 $3.09 Million
Q4 2018 Feb 14, 2019	SELL	$10.57 - $19.29 $3.07 Million - $5.6 Million	-290,427 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.31 - $29.82 $5.03 Million - $8.66 Million	290,427 New	290,427 $5.41 Million

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account